| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
RS virusPalivizumabAdenovirusCMVInfluenzaHanta virusSARSVarizella zoster virusFilovirusVaccine regulation| 1 | 2007 | Respiratory syncytial virus: seasonal data for regions of Florida and implications for palivizumab. | 
| + | - | nl | South Med J 100(7):669-76 (2007) Bauman J |
| 2 | 2002 | Respiratory syncytial virus infection and the primary care physician. | 
| + | - | nl | South Med J 95(3):353-7 (2002) |
| 3 | 2006 | Think outside the box: extrapulmonary manifestations of severe respiratory syncytial virus infection. | 
| + | - | nl | Crit Care 10(4):159 (2006) Thorburn K |
| 4 | 2006 | Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review. | 
| + | - | nl | Crit Care 10(4):R107 (2006) |
| 5 | 2008 | Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants. | 
| + | - | nl | Biologics 2(3):433-9 (2008) |
| 6 | 2007 | Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV). | 
| + | - | nl | Biologics 1(1):33-43 (2007) |
| 7 | 2002 | The quest for an efficacious antiviral for respiratory syncytial virus. | 
| + | - | nl | Antivir Chem Chemother 13(6):325-44 (2002) |
| 8 | 2007 | VII International Symposium on Respiratory Viral Infections. | 
| + | - | nl | Antivir Ther 12(4 Pt B):671-93 (2007) |
| 9 | 2007 | Respiratory syncytial virus infection in adults. | 
| + | - | nl | Antivir Ther 12(4 Pt B):659-70 (2007) |
| 10 | 2008 | Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation. | 
| + | - | nl | Health Technol Assess 12(36):iii, ix-x, 1-86 (2008) |
| 11 | 2008 | Human genetic factors and respiratory syncytial virus disease severity. | 
| + | - | nl | Clin Microbiol Rev 21(4):686-703 (2008) |
| 12 | 2008 | Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma. | 
| + | - | nl | Clin Microbiol Rev 21(3):495-504 (2008) |
| 13 | 2005 | Immune responses and disease enhancement during respiratory syncytial virus infection. | 
| + | - | nl | Clin Microbiol Rev 18(3):541-55 (2005) |
| 14 | 2000 | Respiratory syncytial virus infection in adults. | 
| + | - | nl | Clin Microbiol Rev 13(3):371-84 (2000) |
| 15 | 2000 | Respiratory syncytial virus genetic and antigenic diversity. | 
| + | - | nl | Clin Microbiol Rev 13(1):1-15, table of contents (2000) |
| 16 | 1999 | Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. | 
| + | - | nl | Clin Microbiol Rev 12(2):298-309 (1999) |
| 17 | 1995 | Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections. | 
| + | - | nl | Clin Microbiol Rev 8(1):22-33 (1995) |
| 18 | 1988 | Detection, pathogenesis, and therapy of respiratory syncytial virus infections. | 
| + | - | nl | Clin Microbiol Rev 1(1):27-39 (1988) |
| 19 | 2003 | Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response. | 
| + | - | nl | Cell Microbiol 5(10):671-80 (2003) |
| 20 | 2007 | A new mechanism for respiratory syncytial virus-induced beta2-adrenergic receptor insensitivity. | 
| + | - | nl | Am J Physiol Lung Cell Mol Physiol 293(2):L279-80 (2007) Clerici C |
| 21 | 2007 | A mechanistic advance in understanding RSV pathogenesis, but still a long way from therapy. | 
| + | - | nl | Am J Respir Cell Mol Biol 37(4):375-7 (2007) |
| 22 | 2001 | Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae. | 
| + | - | nl | Am J Respir Crit Care Med 163(3 Pt 2):S18-21 (2001) |
| 23 | 2001 | Treatment and prevention of respiratory syncytial virus lower respiratory tract infection. Long-term effects on respiratory outcomes. | 
| + | - | nl | Am J Respir Crit Care Med 163(3 Pt 2):S14-7 (2001) |
| 24 | 2001 | Potential mechanisms causing delayed effects of respiratory syncytial virus infection. | 
| + | - | nl | Am J Respir Crit Care Med 163(3 Pt 2):S10-3 (2001) |
| 25 | 2007 | Respiratory syncytial virus: a sleeping giant? | 
| + | - | nl | Eur Respir J 30(6):1029-31 (2007) Fleming DM |
| 26 | 2001 | Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases. | 
| + | - | nl | Eur Respir J 18(6):1044-58 (2001) |
| 27 | 2003 | Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. | 
| + | - | nl | Pediatrics 112(6 Pt 1):1442-6 (2003) |
| 28 | 2003 | Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. | 
| + | - | nl | Pediatrics 112(3 Pt 1):548-52 (2003) |
| 29 | 1979 | The pathogenesis of respiratory viral infection. | 
| + | - | nl | Postgrad Med J 55(640):122-7 (1979) |
| 30 | 2005 | Pathogenesis of respiratory syncytial virus infection in the murine model. | 
| + | - | nl | Proc Am Thorac Soc 2(2):110-5 (2005) |
| 31 | 2002 | Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing. | 
| + | - | nl | Respir Res 3 Suppl 1(-):S40-5 (2002) |
| 32 | 2002 | Immunoprophylaxis of respiratory syncytial virus: global experience. | 
| + | - | nl | Respir Res 3 Suppl 1(-):S26-33 (2002) |
| 33 | 2002 | Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link. | 
| + | - | nl | Respir Res 3 Suppl 1(-):S21-5 (2002) |
| 34 | 2002 | Potential therapeutic implications of new insights into respiratory syncytial virus disease. | 
| + | - | nl | Respir Res 3 Suppl 1(-):S15-20 (2002) |
| 35 | 2002 | Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease. | 
| + | - | nl | Respir Res 3 Suppl 1(-):S8-14 (2002) |
| 36 | 2006 | Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease. | 
| + | - | nl | Arch Pediatr Adolesc Med 160(10):1070-6 (2006) |
| 37 | 2003 | Systematic review of the biology and medical management of respiratory syncytial virus infection. | 
| + | - | nl | Respir Care 48(3):209-31; discussion 231-3 (2003) |
| 38 | 2010 | Pharmacologic advances in the treatment and prevention of respiratory syncytial virus. | 
| + | - | nl | Clin Infect Dis 50(9):1258-67 (2010) |
| 39 | 2008 | Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. | 
| + | - | nl | Clin Infect Dis 46(3):402-12 (2008) |
| 40 | 2007 | A new direction in understanding the pathogenesis of respiratory syncytial virus bronchiolitis: how real infants suffer. | 
| + | - | nl | J Infect Dis 195(8):1084-6 (2007) |
| 41 | 2010 | Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. | 
| + | - | nl | Clin Microbiol Rev 23(1):74-98 (2010) |
| 42 | 2010 | Evaluation of therapeutics for RSV: an important step forward. | 
| + | - | nl | Am J Respir Crit Care Med 182(10):1217-9 (2010) Boeckh M |
| 43 | 2008 | Bench-to-bedside review: rare and common viral infections in the intensive care unit--linking pathophysiology to clinical presentation. | 
| + | - | nl | Crit Care 12(4):219 (2008) |
| 44 | 2011 | Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses. | 
| + | - | nl | Health Technol Assess 15(5):iii-iv, 1-124 (2011) |
| 45 | 2007 | Optimizing the delivery and use of a new monoclonal antibody in children with congenital heart disease: a successful provincial respiratory syncytial virus prophylaxis program. | 
| + | - | nl | Can J Cardiol 23(6):463-6 (2007) |
| 46 | 2007 | Respiratory syncytial virus: the possible trigger of airway remodeling through matrix metalloproteinase activation? | 
| + | - | nl | Chin Med J (Engl) 120(1):3-4 (2007) |
| 47 | 2009 | The host response and molecular pathogenesis associated with respiratory syncytial virus infection. | 
| + | - | nl | Future Microbiol 4(3):279-97 (2009) |